Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 3MG/ML;EQ 3MG BASE/ML | 0 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
FDA Submissions
| ORIG | 1 | AP | 2009-07-31 | |
LABELING; Labeling | SUPPL | 4 | AP | 2016-04-19 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2016-04-19 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 18 | AP | 2022-01-13 | UNKNOWN |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 7 |
SUPPL | 18 | Null | 15 |
TE Codes
CDER Filings
AM REGENT
cder:Array
(
[0] => Array
(
[ApplNo] => 90747
[companyName] => AM REGENT
[docInserts] => ["",""]
[products] => [{"drugName":"BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE","activeIngredients":"BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE","strength":"3MG\/ML;EQ 3MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE","submission":"BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE","actionType":"3MG\/ML;EQ 3MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)